Product
OTX-TKI/Sham
1 clinical trial
1 indication
Indication
Age-Related Macular DegenerationClinical trial
A Prospective Multicenter, Double-Masked, Randomized, Parallel-Group, Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI (Axitinib Implant) for Intravitreal Use in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)Status: Completed, Estimated PCD: 2023-02-06